In order to analyze the correlation between SHARPIN expression and breast cancer subtype markers, 133 breast tumor tissues are collected and immunohistochemistry (IHC) is applied for examine the protein level of SHARPIN, ERα, progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2). Here, ESR1 is linked to breast carcinoma.